Memantine as Adjunctive Therapy for Schizophrenia Negative Symptoms

NCT00757978 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: memantine
DRUG: placebo

Sponsor

Hospital de Clinicas de Porto Alegre